Dr. Valdes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3659 S Miami Ave
Ste 2007
Miami, FL 33133Phone+1 305-856-6753Fax+1 305-856-6758
Education & Training
Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 2002 - 2005- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2000 - 2002
University of California (San Francisco)Internship, Internal Medicine, 1998 - 1999
Johns Hopkins University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2000 - Present
FL State Medical License 2004 - 2027
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer Start of enrollment: 2017 May 04
Publications & Presentations
PubMed
- 18 citationsAKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.Maysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis, Elisa Baldelli, Emna El Gazzah
NPJ Precision Oncology. 2023-02-16 - 1 citationsImpact of genomic assays on treatment and outcomes in locally advanced breast cancer.Omar Picado, Deukwoo Kwon, Kristin Rojas, Jessica Crystal, Lora Wang
Breast Cancer Research and Treatment. 2022-07-01 - 25 citationsPhase I study of nelfinavir in liposarcomaJanet Pan, Michelle Mott, Bixin Xi, Ernestine Hepner, Min Guan
Cancer Chemotherapy and Pharmacology. 2012-09-16
Press Mentions
BostonGene Unveils Transformative Breast Cancer Research at 2024 San Antonio Breast Cancer Symposium, Showcasing Precision Tools for Tailored Treatment ApproachesDecember 10th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
